Gabelli & CO Investment Advisers, Inc. Horizon Therapeutics Public LTD CO Transaction History

Gabelli & CO Investment Advisers, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$98.98 - $115.74 $2.24 Million - $2.62 Million	22,600 Added 6.88%	351,075 $40.6 Million
Q2 2023 Aug 10, 2023	BUY	$96.34 - $112.38 $2.2 Million - $2.57 Million	22,875 Added 7.49%	328,475 $33.8 Million
Q1 2023 May 12, 2023	BUY	$107.32 - $113.5 $16.9 Million - $17.9 Million	157,900 Added 106.91%	305,600 $33.4 Million
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $9.22 Million - $16.8 Million	147,700 New	147,700 $16.8 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Gabelli & CO Investment Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Gabelli & CO Investment Advisers, Inc. with notifications on news.